Guinea vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Syrian Arab Republic
2.9%
in 2024
Guinea rank
8th
Syrian Arab Republic rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 2.8% in Guinea, a difference of 0.1%.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
Guinea ranks 8th and Syrian Arab Republic ranks 6th of 247 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 3.5% | 0.7% | Syrian Arab Republic |
| 2020s | 2.7% | 3.4% | 0.7% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 2.8% in Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Syrian Arab Republic?
- 0.1%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Guinea and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 8th and Syrian Arab Republic ranks 6th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.